AT 1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular Myocytes
- 1 August 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 42 (2), 206-212
- https://doi.org/10.1161/01.hyp.0000082814.62655.85
Abstract
Enhanced tissue angiotensin (Ang) II levels have been reported in diabetes and might lead to cardiac dysfunction through oxidative stress. This study examined the effect of blocking the Ang II type 1 (AT 1 ) receptor on high glucose–induced cardiac contractile dysfunction. Rat ventricular myocytes were maintained in normal- (NG, 5.5 mmol/L) or high- (HG, 25.5 mmol/L) glucose medium for 24 hours. Mechanical and intracellular Ca 2+ properties were assessed as peak shortening (PS), time to PS (TPS), time to 90% relengthening (TR 90 ), maximal velocity of shortening/relengthening (± dL / dt ), and intracellular Ca 2+ decay (τ). HG myocytes exhibited normal PS; decreased ± dL / dt ; and prolonged TPS, TR 90 , and τ. Interestingly, the HG-induced abnormalities were prevented with the AT 1 blocker L-158,809 (10 to 1000 nmol/L) but not the Janus kinase-2 (JAK2) inhibitor AG-490 (10 to 100 μmol/L). The only effect of AT 1 blockade on NG myocytes was enhanced PS at 1000 nmol/L. AT 1 antagonist-elicited cardiac protection against HG was nullified by the NADPH oxidase activator sodium dodecyl sulfate (80 μmol/L) and mimicked by the NADPH oxidase inhibitors diphenyleneiodonium (10 μmol/L) or apocynin (100 μmol/L). Western blot analysis confirmed that the protein abundance of NADPH oxidase subunit p47 phox and the AT 1 but not the AT 2 receptor was enhanced in HG myocytes. In addition, the HG-induced increase of p47 phox was prevented by L-158,809. Enhanced reactive oxygen species production observed in HG myocytes was prevented by AT 1 blockade or NADPH oxidase inhibition. Collectively, our data suggest that local Ang II, acting via AT 1 receptor–mediated NADPH oxidase activation, is involved in hyperglycemia-induced cardiomyocyte dysfunction, which might play a role in diabetic cardiomyopathy.Keywords
This publication has 21 references indexed in Scilit:
- Hypertension, Angiotensin II, and Oxidative StressThe New England Journal of Medicine, 2002
- Characterization of Contractile Function in Diabetic Hypertensive Cardiomyopathy in Adult Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 2001
- Cardiomyocyte Dysfunction in Sucrose-Fed Rats Is Associated With Insulin ResistanceDiabetes, 2001
- Diabetic cardiomyopathy: fact or fiction?Heart, 2001
- Oxidative stress and diabetic cardiomyopathy: a brief review.Cardiovascular Toxicology, 2001
- Reactive oxygen species as mediators of angiotensin II signalingRegulatory Peptides, 2000
- The role of Jak/STAT signaling in heart tissue renin-angiotensin systemMolecular and Cellular Biochemistry, 2000
- Metabolic disturbances in diabetic cardiomyopathyMolecular and Cellular Biochemistry, 1998
- Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT PathwayAnnual Review of Biochemistry, 1995